This announcement is a separate document:
大参林：中证鹏元关于终止“2019年大参林医药集团股份有限公司可转换公司债券信用评级”的公告
Dashenlin: China Securities Pengyuan's announcement on the termination of the “2019 Dashenlin Pharmaceutical Group Co., Ltd. Convertible Corporate Bond Credit Rating”
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.